The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
( R )-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells
Open accessAbstract
Significance: Protein methyltransferases constitute an emerging but undercharacterized class of therapeutic targets with diverse roles in normal human biology and disease. Small-molecule “chemical probes” can be powerful tools for the functional characterization of such enzymes, and here we report the discovery of ( R )-PFI-2—a first-in-class, potent, highly selective, and cell-active inhibitor of the methyltransferase activity of SETD7 [SET domain containing (lysine methyltransferase) 7]—and two related compounds for control and chemoproteomics studies. We used these compounds to characterize the role of SETD7 in signaling, in the Hippo pathway, that controls cell growth and organ size. Our work establishes a chemical biology tool kit for the study of the diverse roles of SETD7 in cells and further validates protein methyltransferases as a druggable target class.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Self-citationLi, Y., Reddy, M. A., Miao, F., Shanmugam, N., Yee, J.-K., Hawkins, D., Ren, B., & Natarajan, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802800200 · Cited by 353
Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes
Yang, J., Huang, J., Dasgupta, M., Sears, N., Miyagi, M., Wang, B., Chance, M. R., Chen, X., Du, Y., Wang, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016147107 · Cited by 340
Structural Basis of Substrate Methylation and Inhibition of SMYD2
Ferguson, A. D., Larsen, N. A., Howard, T., Pollard, H., Green, I., Grande, C., Cheung, T., Garcia-Arenas, R., Cowen, S., Wu, J., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.011 · Cited by 203
Distinguishing Hyperglycemic Changes by Set7 in Vascular Endothelial Cells
Okabe, J., Orlowski, C., Balcerczyk, A., Tikellis, C., Thomas, M. C., Cooper, M. E., & El-Osta, A. (2012) · Circulation Research · doi:10.1161/circresaha.112.266171 · Cited by 180
Research works printed but not linked: 30
- K Nishioka, et al., Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev 16, 479–489 (2002). · DOI · Paper page
- H Wang, et al., Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. Mol Cell 8, 1207–1217 (2001). · DOI · Paper page
- DR Calnan, et al., Methylation by Set9 modulates FoxO3 stability and transcriptional activity. Aging (Albany, NY) 4, 462–479 (2012). · DOI
- SM Carr, S Munro, B Kessler, U Oppermann, NB La Thangue, Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein. EMBO J 30, 317–327 (2011). · DOI
- S Chuikov, et al., Regulation of p53 activity through lysine methylation. Nature 432, 353–360 (2004). · DOI · Paper page
- TG Deering, T Ogihara, AP Trace, B Maier, RG Mirmira, Methyltransferase Set7/9 maintains transcription and euchromatin structure at islet-enriched genes. Diabetes 58, 185–193 (2009). · DOI
- A Dhayalan, S Kudithipudi, P Rathert, A Jeltsch, Specificity analysis-based identification of new methylation targets of the SET7/9 protein lysine methyltransferase. Chem Biol 18, 111–120 (2011). · DOI · Paper page
- CK Ea, D Baltimore, Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci USA 106, 18972–18977 (2009). · DOI · Paper page
- PO Estève, et al., Regulation of DNMT1 stability through SET7-mediated lysine methylation in mammalian cells. Proc Natl Acad Sci USA 106, 5076–5081 (2009). · DOI · Paper page
- ST Keating, A El-Osta, Transcriptional regulation by the Set7 lysine methyltransferase. Epigenetics 8, 361–372 (2013). · DOI
- A Kouskouti, E Scheer, A Staub, L Tora, I Talianidis, Gene-specific modulation of TAF10 function by SET9-mediated methylation. Mol Cell 14, 175–182 (2004). · DOI · Paper page
- S Pagans, et al., The cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. Cell Host Microbe 7, 234–244 (2010). · DOI
- K Subramanian, et al., Regulation of estrogen receptor alpha by the SET7 lysine methyltransferase. Mol Cell 30, 336–347 (2008). · DOI · Paper page
- J Wang, et al., The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nat Genet 41, 125–129 (2009). · DOI · Paper page
- XD Yang, et al., Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit. EMBO J 28, 1055–1066 (2009). · DOI · Paper page
- S Campaner, et al., The methyltransferase Set7/9 (Setd7) is dispensable for the p53-mediated DNA damage response in vivo. Mol Cell 43, 681–688 (2011). · DOI
- B Lehnertz, et al., p53-dependent transcription and tumor suppression are not affected in Set7/9-deficient mice. Mol Cell 43, 673–680 (2011). · DOI
- M Schapira, Structural chemistry of human SET domain protein methyltransferases. Curr Chem Genomics 5, 85–94 (2011). · DOI
- A Garbino, et al., Molecular evolution of the junctophilin gene family. Physiol Genomics 37, 175–186 (2009). · DOI
- ME Bunnage, EL Chekler, LH Jones, Target validation using chemical probes. Nat Chem Biol 9, 195–199 (2013). · DOI · Paper page
- SV Frye, The art of the chemical probe. Nat Chem Biol 6, 159–161 (2010). · DOI · Paper page
- RA Copeland, et al., Recombinant human dihydroorotate dehydrogenase: Expression, purification, and characterization of a catalytically functional truncated enzyme. Arch Biochem Biophys 323, 79–86 (1995). · DOI
- C Ribeiro, JC Esteves da Silva, Kinetics of inhibition of firefly luciferase by oxyluciferin and dehydroluciferyl-adenylate. Photochem Photobiol Sci 7, 1085–1090 (2008). · doi:10.1039/b809935a
- B Xiao, et al., Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature 421, 652–656 (2003). · DOI · Paper page
- G Ibáñez, JL McBean, YM Astudillo, M Luo, An enzyme-coupled ultrasensitive luminescence assay for protein methyltransferases. Anal Biochem 401, 203–210 (2010). · DOI
- RA Copeland Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists (Wiley, Hoboken, NJ, 2013). · DOI · Paper page
- MJ Oudhoff, et al., Control of the hippo pathway by Set7-dependent methylation of Yap. Dev Cell 26, 188–194 (2013). · DOI · Paper page
- D Pan, The hippo signaling pathway in development and cancer. Dev Cell 19, 491–505 (2010). · DOI · Paper page
- M Vedadi, et al., A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol 7, 566–574 (2011). · DOI · Paper page
- TJ Wigle, RA Copeland, Drugging the human methylome: An emerging modality for reversible control of aberrant gene transcription. Curr Opin Chem Biol 17, 369–378 (2013). · DOI
Cited by
Inhibitors of Protein Methyltransferases and Demethylases
Kaniskan, H. Ü., Martini, M. L., & Jin, J. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00801 · Cited by 297
A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases
Eram, M. S., Shen, Y., Szewczyk, M. M., Wu, H., Senisterra, G., Li, F., Butler, K. V., Kaniskan, H. Ü., Speed, B. A., dela Seña, C., et al. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00839 · Cited by 289
Self-citationChemical and Biochemical Perspectives of Protein Lysine Methylation
Luo, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00008 · Cited by 284
The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
He, Y., Selvaraju, S., Curtin, M. L., Jakob, C. G., Zhu, H., Comess, K. M., Shaw, B., The, J., Lima-Fernandes, E., Szewczyk, M. M., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2306 · Cited by 224
Self-citationEpigenetic Changes in Diabetes and Cardiovascular Risk
Keating, S. T., Plutzky, J., & El-Osta, A. (2016) · Circulation Research · doi:10.1161/circresaha.116.306819 · Cited by 139
Metadata
- Authors
- Barsyte-Lovejoy, D., Li, F., Oudhoff, M. J., Tatlock, J. H., Dong, A., Zeng, H., Wu, H., Freeman, S. A., Schapira, M., Senisterra, G. A., Kuznetsova, E., Marcellus, R., Allali-Hassani, A., Kennedy, S., Lambert, J.-P., Couzens, A. L., Aman, A., Gingras, A.-C., Al-Awar, R., Fish, P. V., Gerstenberger, B. S., Roberts, L., Benn, C. L., Grimley, R. L., Braam, M. J. S., Rossi, F. M. V., Sudol, M., Brown, P. J., Bunnage, M. E., Owen, D. R., Zaph, C., Vedadi, M., & Arrowsmith, C. H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2014-08-18
- Volume
- 111
- Issue
- 35
- Pages
- 12853-12858
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2034104594
- Cited by
- 185
- References
- 5
- FWCI
- 6.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ( R )-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells. https://app.cochat.ai/papers/10.1073/pnas.1407358111
- The paper
- Barsyte-Lovejoy, D., Li, F., Oudhoff, M. J., Tatlock, J. H., Dong, A., Zeng, H., Wu, H., Freeman, S. A., Schapira, M., Senisterra, G. A., Kuznetsova, E., Marcellus, R., Allali-Hassani, A., Kennedy, S., Lambert, J.-P., Couzens, A. L., Aman, A., Gingras, A.-C., Al-Awar, R., . . . Arrowsmith, C. H. (2014). ( R )-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1407358111
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.